Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Stupp

Showing results (1-10 of 313) with videos related to

Pageof 32
Sort By:
Journal of Oncology Practice|November 13, 2019
Changing Paradigms in the Treatment of Brain MetastasesRoger Stupp
The Lancet. Oncology|December 8, 2018
Drug development for glioma: are we repeating the same mistakes?Roger Stupp
JAMA|May 2, 2018
Quality of Life in Patients With Glioblastoma Treated With Tumor-Treating Fields-ReplyRoger Stupp, Zvi Ram
Current Opinion in Neurology|November 6, 2010
2010: neuro-oncology is moving!Roger Stupp, Michael Weller
Current Opinion in Neurology|September 23, 2009
Approval of new drugs for glioblastomaMichael Weller, Roger Stupp
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Integrin inhibitors reaching the clinicRoger Stupp, Curzio Ruegg
Neuro-Oncology|May 16, 2014
Questions regarding the optimal use of bevacizumab in glioblastoma: a moving targetRoger Stupp, Michael Weller
Targeted Oncology|September 10, 2010
Targeted therapies on the horizon for malignant gliomaSilvia Hofer, Roger Stupp
Expert Review of Anticancer Therapy|August 24, 2006
Temozolomide: a milestone in neuro-oncology and beyond?Nicole Mutter, Roger Stupp
Current Opinion in Neurology|October 9, 2012
Prime time for molecular marker diagnostics in neuro-oncologyMichael Weller, Roger Stupp
Pageof 32

Showing results (1-10 of 313) with videos related to

Sort By:
Pageof 32
Journal of Oncology Practice|November 13, 2019
Changing Paradigms in the Treatment of Brain MetastasesRoger Stupp
The Lancet. Oncology|December 8, 2018
Drug development for glioma: are we repeating the same mistakes?Roger Stupp
JAMA|May 2, 2018
Quality of Life in Patients With Glioblastoma Treated With Tumor-Treating Fields-ReplyRoger Stupp, Zvi Ram
Current Opinion in Neurology|November 6, 2010
2010: neuro-oncology is moving!Roger Stupp, Michael Weller
Current Opinion in Neurology|September 23, 2009
Approval of new drugs for glioblastomaMichael Weller, Roger Stupp
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Integrin inhibitors reaching the clinicRoger Stupp, Curzio Ruegg
Neuro-Oncology|May 16, 2014
Questions regarding the optimal use of bevacizumab in glioblastoma: a moving targetRoger Stupp, Michael Weller
Targeted Oncology|September 10, 2010
Targeted therapies on the horizon for malignant gliomaSilvia Hofer, Roger Stupp
Expert Review of Anticancer Therapy|August 24, 2006
Temozolomide: a milestone in neuro-oncology and beyond?Nicole Mutter, Roger Stupp
Current Opinion in Neurology|October 9, 2012
Prime time for molecular marker diagnostics in neuro-oncologyMichael Weller, Roger Stupp
Pageof 32